NCT00937586Active, not recruiting
Prostate Cancer Prospective Cohort
Source: ClinicalTrials.gov · Last updated 17 Dec 2025
Brief summary (registry, in English)
The overall purpose of this research is to determine if certain genes increase the chance of developing prostate cancer and once diagnosed increase the chance of the prostate cancer spreading to other parts of the body.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 1937 (actual)
- First submitted
- 10 Jul 2009
- Start date
- May 2000
- Primary completion date
- Jun 2027
- Lead sponsor
- Washington University School of Medicine
- Diseases
- Prostate cancer
- NCT number
- NCT00937586
What you commit to
- Study type: Observational
- Participants enrolled: 1937
- From May 2000 to the primary completion date, Jun 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Newly diagnosed patients: 1. inability to give informed consent
Who the study is looking for
- Newly diagnosed patients: 1. newly diagnosis of prostate cancer 2. untreated except for neoadjuvant systemic therapy.
Age in the registry: 18 years to 100 years · Sex: Male · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Washington University School of Medicine Coordinator of this site? Confirm its status | St Louis | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.